New GLP-1 Complaint Alleges Novo Nordisk Failed to Warn of Ileus Risks
A new complaint in the GLP-1 multidistrict litigation accuses Novo Nordisk of failing to warn patients about the risk of ileus and intestinal obstruction from Ozempic.
WILLIAMS v. WALMART, INC. et al